Nanomaterials in the treatment and diagnosis of rheumatoid arthritis: Advanced approaches
- PMID: 38844139
- DOI: 10.1016/j.slast.2024.100146
Nanomaterials in the treatment and diagnosis of rheumatoid arthritis: Advanced approaches
Abstract
Rheumatoid arthritis (RA), a chronic inflammatory condition that affects persons between the ages of 20 and 40, causes synovium inflammation, cartilage loss, and joint discomfort as some of its symptoms. Diagnostic techniques for RA have traditionally been split into two main categories: imaging and serological tests. However, significant issues are associated with both of these methods. Imaging methods are costly and only helpful in people with obvious symptoms, while serological assays are time-consuming and require specialist knowledge. The drawbacks of these traditional techniques have led to the development of novel diagnostic approaches. The unique properties of nanomaterials make them well-suited as biosensors. Their compact dimensions are frequently cited for their outstanding performance, and their positive impact on the signal-to-noise ratio accounts for their capacity to detect biomarkers at low detection limits, with excellent repeatability and a robust dynamic range. In this review, we discuss the use of nanomaterials in RA theranostics. Scientists have recently synthesized, characterized, and modified nanomaterials and biomarkers commonly used to enhance RA diagnosis and therapy capabilities. We hope to provide scientists with the promising potential that nanomaterials hold for future theranostics and offer suggestions on further improving nanomaterials as biosensors, particularly for detecting autoimmune disorders.
Keywords: Biomarker; Biosensor; Diagnosis; Nanomaterials; Rheumatoid arthritis; Therapy.
Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Nanomaterials for the Diagnosis and Treatment of Inflammatory Arthritis.Int J Mol Sci. 2021 Mar 18;22(6):3092. doi: 10.3390/ijms22063092. Int J Mol Sci. 2021. PMID: 33803502 Free PMC article. Review.
-
Optical Biosensors for the Detection of Rheumatoid Arthritis (RA) Biomarkers: A Comprehensive Review.Sensors (Basel). 2020 Nov 4;20(21):6289. doi: 10.3390/s20216289. Sensors (Basel). 2020. PMID: 33158306 Free PMC article. Review.
-
Nanomedicine: an emerging era of theranostics and therapeutics for rheumatoid arthritis.Rheumatology (Oxford). 2019 Oct 1;58(10):1715-1721. doi: 10.1093/rheumatology/kez286. Rheumatology (Oxford). 2019. PMID: 31377812 Review.
-
Silicon nanomaterials platform for bioimaging, biosensing, and cancer therapy.Acc Chem Res. 2014 Feb 18;47(2):612-23. doi: 10.1021/ar400221g. Epub 2014 Jan 7. Acc Chem Res. 2014. PMID: 24397270 Review.
-
Current trends in theranostics for rheumatoid arthritis.Eur J Pharm Sci. 2020 Mar 30;145:105240. doi: 10.1016/j.ejps.2020.105240. Epub 2020 Jan 24. Eur J Pharm Sci. 2020. PMID: 31987984 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical